NM_001161352.2:c.808+19691A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001161352.2(KCNMA1):​c.808+19691A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 152,102 control chromosomes in the GnomAD database, including 5,656 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5656 hom., cov: 32)

Consequence

KCNMA1
NM_001161352.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0510

Publications

7 publications found
Variant links:
Genes affected
KCNMA1 (HGNC:6284): (potassium calcium-activated channel subfamily M alpha 1) This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
KCNMA1 Gene-Disease associations (from GenCC):
  • generalized epilepsy-paroxysmal dyskinesia syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet, Illumina
  • Liang-Wang syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • cerebellar atrophy, developmental delay, and seizures
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001161352.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNMA1
NM_001161352.2
MANE Select
c.808+19691A>G
intron
N/ANP_001154824.1Q12791-1
KCNMA1
NM_001437422.1
c.940+19691A>G
intron
N/ANP_001424351.1
KCNMA1
NM_001161353.2
c.808+19691A>G
intron
N/ANP_001154825.1Q12791-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNMA1
ENST00000286628.14
TSL:1 MANE Select
c.808+19691A>G
intron
N/AENSP00000286628.8Q12791-1
KCNMA1
ENST00000626620.3
TSL:1
c.808+19691A>G
intron
N/AENSP00000485867.1Q12791-2
KCNMA1
ENST00000639406.1
TSL:1
c.808+19691A>G
intron
N/AENSP00000491732.1B7ZMF5

Frequencies

GnomAD3 genomes
AF:
0.262
AC:
39877
AN:
151984
Hom.:
5652
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.301
Gnomad AMI
AF:
0.331
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.250
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.101
Gnomad FIN
AF:
0.358
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.273
Gnomad OTH
AF:
0.249
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.262
AC:
39906
AN:
152102
Hom.:
5656
Cov.:
32
AF XY:
0.259
AC XY:
19266
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.300
AC:
12466
AN:
41486
American (AMR)
AF:
0.185
AC:
2830
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
868
AN:
3466
East Asian (EAS)
AF:
0.00155
AC:
8
AN:
5174
South Asian (SAS)
AF:
0.101
AC:
486
AN:
4824
European-Finnish (FIN)
AF:
0.358
AC:
3789
AN:
10588
Middle Eastern (MID)
AF:
0.201
AC:
59
AN:
294
European-Non Finnish (NFE)
AF:
0.273
AC:
18580
AN:
67962
Other (OTH)
AF:
0.246
AC:
519
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1487
2975
4462
5950
7437
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.261
Hom.:
5364
Bravo
AF:
0.251
Asia WGS
AF:
0.0530
AC:
187
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.9
DANN
Benign
0.58
PhyloP100
0.051
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1516510; hg19: chr10-78923488; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.